BIOMAT Database Logo BIOMAT Database Logo

[Neuropsychiatric side effects of intrathecal ziconotide]. 2011

Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D018712 Analgesics, Non-Narcotic A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. Non Opioid Analgesic,Non-Opioid Analgesic,Nonopioid Analgesic,Nonopioid Analgesics,Analgesics, Nonnarcotic,Analgesics, Nonopioid,Non-Opioid Analgesics,Analgesic, Non Opioid,Analgesic, Non-Opioid,Analgesic, Nonopioid,Analgesics, Non Narcotic,Analgesics, Non-Opioid,Non Opioid Analgesics,Non-Narcotic Analgesics,Nonnarcotic Analgesics,Opioid Analgesic, Non
D020960 omega-Conotoxins A family of structurally related neurotoxic peptides from mollusk venom that inhibit voltage-activated entry of calcium into the presynaptic membrane. They selectively inhibit N-, P-, and Q-type calcium channels. omega-Conotoxin,omega Conotoxin,omega Conotoxins

Related Publications

Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Adverse effects associated with the intrathecal administration of ziconotide.
March 2000, Pain,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Intrathecal ziconotide for chronic pain.
October 2004, JAMA,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Using ziconotide for intrathecal infusions.
December 2008, Nursing,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Intrathecal ziconotide for refractory pain.
July 2004, Expert opinion on investigational drugs,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).
November 2020, Pain medicine (Malden, Mass.),
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).
February 2018, Pain practice : the official journal of World Institute of Pain,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Trigeminal neuralgia relief with intrathecal ziconotide.
May 2011, The Clinical journal of pain,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Intrathecal ziconotide for refractory chronic pain.
January 2006, The Annals of pharmacotherapy,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
[Neuropsychiatric side effects of HAART].
May 2011, MMW Fortschritte der Medizin,
Fernando Ayuga-Loro, and Ángela Brocalero-Camacho, and M Visitación Quintas-López, and José R Cabrera-Feria
Neuropsychiatric side effects of montelukast.
September 2019, The Journal of pediatrics,
Copied contents to your clipboard!